both our PhD students Lena and Mathias received Travel Awards for their Posters at the 10th International Conference on Autoimmunity by @AegeanConf 🥳🎉 #ProudPI
Treating Inflammatory Bowel Disease in Mice with Engineered Probiotic
Researchers report that they have developed an engineered yeast that can induce multiple effects for treating Inflammatory bowel disease. Learn more: https://t.co/Vvs7Rr1loK
An yeast engineered to release an ATPase in response to extracellular ATP (a proinflammatory mediator) brings down intestinal inflammation in mouse models of inflammatory bowel disease. Work from Francisco Quintana and colleagues @harvardmed#NBThighligh
https://t.co/JAf6iVq2me
Finally out! Special congrats to @BenMiScott and many thanks to all hands that help us @QuintanaLabHMS@LiliSanmarco. Look at our cool technology to treat IBD and potentially other inflammatory diseases
Check out our latest work @NatureMedicine. @BenMiScott and @CrisGV85 engineered probiotic yeasts to sense and degrade proinflammatory cues in the inflamed gut for the treatment of IBD. Great synergic effort with @opsinlab 🍾🥳
https://t.co/yYFwsRLZXP
Happy Bday to me and our paper! Finally got out in @ScienceMagazine. Thanks to my co-authors @icclarker and @mwheeler0 in @QuintanaLabHMS. We were able to identify and target Astrocytes and Microglia interactions that drive neuroinflammation in EAE.
https://t.co/Tom2M89wss
So proud to be part of this amazing team. Special thanks to Dr Chun-Cheih Chao for letting me help him with this great story. Congrats. 😃
Metabolic Control of Astrocyte Pathogenic Activity via cPLA2-MAVS https://t.co/ymWV2PTSfe
I am honoured to share with you my very first corresponding author work: Nanog regulates Pou3f1 expression during gastrulation. Big thanks to all the team, especially to the first co-authors @PeliZorro @isabel_rollan and co-corresponding @MigManzanares
https://t.co/oDhkKf3n5I